Biovail news

2009年10月6日星期二20:08 BJT

路透中国 - 52 minutes ago
Oct 6 (Reuters) - Acadia Pharmaceuticals Inc (ACAD.O: 行情) and its partner Biovail Corp (BVF.TO: 行情) decided to conduct a third late-stage trial for pimavanserin, their experimental drug for ...

STOCKS NEWS US-Acadia, Biovail plan more study on drug

Reuters UK - 31 minutes ago
Acadia Pharmaceuticals Inc (ACAD.O) and its partner Biovail Corp (BVF.N) (BVF.TO) on Tuesday said they decided to conduct a third late-stage trial for their experimental drug for psychosis related ...

BRIEF-Biovail gives update on pimavanserin development program

Interactive Investor - 26 minutes ago
Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. Registered Office: Standon House, 21 Mansell Street ...

Biovail Provides Update on Pimavanserin Collaborative Development Program

Business Wire - 3 minutes ago
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE/TSX: BVF) today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in ...

ACADIA Pharmaceuticals Provides Update on Pimavanserin Collaborative Development Program

Business Wire - 3 minutes ago
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel ...

Santhera Reports Closing of Juvantia Acquisition and Final Upfront Payment from Partner Biovail

Biovail, Boeing, Sara Lee, HSBC in focus

MarketWatch - 43 minutes ago
By MarketWatch US stock market futures turned lower after disappointing durable goods order data Friday. Research In Motion shares were set for a sharp fall after a disappointing earnings forecast ...

Durable goods. USD, Iran, RIM, Biovail – Vialoux

JP Morgan starts Biovail at overweight rating

MarketWatch - 1 hour ago
NEW YORK (MarketWatch) -- Analysts at JP Morgan initiated coverage of pharmaceutical company Biovail Corp. on Friday with an overweight rating and a price target of $19. "Overall, we are ...

Habitat sheds built in park

Winnipeg Sun - 8 hours ago
Biovail, a specialty pharmaceutical company based in Steinbach, partnered up with Habitat for Humanity to build 25 garden sheds for the not-for-profit housing charity on Friday, Sept. 18 in ...